New Results
Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2
View ORCID ProfileGustavo Gámez, View ORCID ProfileJuan A. Hermoso, View ORCID ProfileCésar Carrasco-López, View ORCID ProfileAlejandro Gómez-Mejia, View ORCID ProfileCarlos E. Muskus, View ORCID ProfileSven Hammerschmidt
doi: https://doi.org/10.1101/2021.04.09.439154
Gustavo Gámez
1Genetics, Regeneration and Cancer (GRC) Research Group, University Research Center (SIU), University of Antioquia, UdeA, 050010 Medellín, Colombia
2Basic and Applied Microbiology (MICROBA) Research Group, School of Microbiology, University of Antioquia, UdeA, 050010 Medellín, Colombia
Juan A. Hermoso
3Department of Crystallography and Structural Biology, Institute of Physical Chemistry “Rocasolano”, CSIC, 28006 Madrid, Spain
César Carrasco-López
4Department of Chemical and Biological Engineering, Princeton University, Princeton NJ 08544
Alejandro Gómez-Mejia
5Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland
Carlos E. Muskus
6Program for the Study and Control of Tropical Diseases-PECET, Faculty of Medicine, University of Antioquia, 050010 Medellín, Colombia
Sven Hammerschmidt
7Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, 17487 Greifswald, Germany

Article usage
Posted April 10, 2021.
Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2
Gustavo Gámez, Juan A. Hermoso, César Carrasco-López, Alejandro Gómez-Mejia, Carlos E. Muskus, Sven Hammerschmidt
bioRxiv 2021.04.09.439154; doi: https://doi.org/10.1101/2021.04.09.439154
Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2
Gustavo Gámez, Juan A. Hermoso, César Carrasco-López, Alejandro Gómez-Mejia, Carlos E. Muskus, Sven Hammerschmidt
bioRxiv 2021.04.09.439154; doi: https://doi.org/10.1101/2021.04.09.439154
Subject Area
Subject Areas
- Biochemistry (8755)
- Bioengineering (6477)
- Bioinformatics (23331)
- Biophysics (11743)
- Cancer Biology (9144)
- Cell Biology (13242)
- Clinical Trials (138)
- Developmental Biology (7412)
- Ecology (11364)
- Epidemiology (2066)
- Evolutionary Biology (15084)
- Genetics (10397)
- Genomics (14006)
- Immunology (9115)
- Microbiology (22036)
- Molecular Biology (8777)
- Neuroscience (47345)
- Paleontology (350)
- Pathology (1420)
- Pharmacology and Toxicology (2480)
- Physiology (3703)
- Plant Biology (8045)
- Synthetic Biology (2207)
- Systems Biology (6014)
- Zoology (1249)